Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best medical stocks to buy now. RBC Capital analyst Brian Abrahams maintained a Hold rating on Gilead Sciences, Inc. (NASDAQ:GILD) on September 29 and set a price target of $98.00. Why Gilead Sciences (GILD) Deserves Attention in the Cheap Quarterly Dividend Stocks Category Gilead Sciences, Inc. (NASDAQ:GILD) reported a 2$7.1 billion compared to the same period last year, with management attributing the ...